Clinical Research Clinical Supply Licensing 
Alta Sciences
DECEMBER 14, 2023
Regulatory Excellence - Licenses for Schedule I through IV drug substances. Adherence to harmonized pharmacy-specific SOPs based on cGMP principles at our three clinical pharmacology units. Electronic security access to the pharmacy and video monitoring. - 24/7 monitoring of temperature and humidity.
The Pharma Data
JANUARY 24, 2021
In clinical research, Cepharanthine exhibits multiple pharmacological properties including anti-oxidative, anti-inflammatory, immuno-regulatory, anti-cancer, anti-viral and anti-parasitic properties. Sairiyo is currently focused on advancing the clinical development of Cepharanthine to treat rare cancer diseases. PharmaDrug Inc.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
OCTOBER 27, 2020
Novartis has been granted an option to in-license global rights of MP0420 and MP0423 – multi-targeted direct-acting antiviral therapeutic candidates demonstrating potential efficacy against COVID-19. During the clinical development stage, Molecular Partners will provide clinical supply.
BioPharma Drive: Drug Pricing
JUNE 9, 2025
As a gastroenterologist for 35 years, with 25 of those spent in clinical research and seven at Altasciences , I recognize that GLP-1s may be one of the most significant medical advancements of our time—a treatment poised to redefine metabolic disease management.
BioPharma Drive: Drug Pricing
JUNE 9, 2025
From pioneering treatments for rare pediatric diseases to exploring natural killer cells for Alzheimers and developing FDA-approved digital therapeutics for fibromyalgia, each episode reveals the scientific ingenuity and personal determination behind medical advances. Its new CEO has to figure out what’s next.
Expert insights. Personalized for you.
40 
Let's personalize your content